Search

Jon E. Angell

Examiner (ID: 3741, Phone: (571)272-0756 , Office: P/1674 )

Most Active Art Unit
1635
Art Unit(s)
1635, 1637, 1674
Total Applications
1431
Issued Applications
721
Pending Applications
199
Abandoned Applications
530

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 111944 [patent_doc_number] => 07718627 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-18 [patent_title] => 'Vector' [patent_app_type] => utility [patent_app_number] => 11/380188 [patent_app_country] => US [patent_app_date] => 2006-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 21438 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/718/07718627.pdf [firstpage_image] =>[orig_patent_app_number] => 11380188 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/380188
Vector Apr 24, 2006 Issued
Array ( [id] => 5732741 [patent_doc_number] => 20060257858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Methods and compositions for introducing biopolymers into cells' [patent_app_type] => utility [patent_app_number] => 11/396287 [patent_app_country] => US [patent_app_date] => 2006-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 27625 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20060257858.pdf [firstpage_image] =>[orig_patent_app_number] => 11396287 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/396287
Methods and compositions for introducing biopolymers into cells Mar 30, 2006 Abandoned
Array ( [id] => 7691477 [patent_doc_number] => 20070232556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'Methods and compositions for the treatment of neurological diseases and disorders' [patent_app_type] => utility [patent_app_number] => 11/396212 [patent_app_country] => US [patent_app_date] => 2006-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 38359 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20070232556.pdf [firstpage_image] =>[orig_patent_app_number] => 11396212 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/396212
Methods and compositions for the treatment of neurological diseases and disorders Mar 30, 2006 Abandoned
Array ( [id] => 5754628 [patent_doc_number] => 20060223777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'Highly functional short hairpin RNA' [patent_app_type] => utility [patent_app_number] => 11/390829 [patent_app_country] => US [patent_app_date] => 2006-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 20296 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20060223777.pdf [firstpage_image] =>[orig_patent_app_number] => 11390829 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/390829
Highly functional short hairpin RNA Mar 27, 2006 Abandoned
Array ( [id] => 4853141 [patent_doc_number] => 20080318884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'Methods for Altering Gene Expression and Methods of Treatment Utilizing Same' [patent_app_type] => utility [patent_app_number] => 11/909691 [patent_app_country] => US [patent_app_date] => 2006-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16418 [patent_no_of_claims] => 122 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20080318884.pdf [firstpage_image] =>[orig_patent_app_number] => 11909691 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/909691
Methods for Altering Gene Expression and Methods of Treatment Utilizing Same Mar 26, 2006 Abandoned
Array ( [id] => 9951157 [patent_doc_number] => 08999943 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-07 [patent_title] => 'Antigene oligomers inhibit transcription' [patent_app_type] => utility [patent_app_number] => 11/376483 [patent_app_country] => US [patent_app_date] => 2006-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10746 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11376483 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/376483
Antigene oligomers inhibit transcription Mar 13, 2006 Issued
Array ( [id] => 5694723 [patent_doc_number] => 20060154870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Method for prevention or treatment of diseases or disorders related to excessive formation of vascular tissue or blood vessels' [patent_app_type] => utility [patent_app_number] => 11/372212 [patent_app_country] => US [patent_app_date] => 2006-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7787 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20060154870.pdf [firstpage_image] =>[orig_patent_app_number] => 11372212 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/372212
Method for prevention or treatment of diseases or disorders related to excessive formation of vascular tissue or blood vessels Mar 9, 2006 Abandoned
Array ( [id] => 5405892 [patent_doc_number] => 20090241207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'Expression of heterologous genes according to a targeted expression profile' [patent_app_type] => utility [patent_app_number] => 11/364042 [patent_app_country] => US [patent_app_date] => 2006-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8836 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20090241207.pdf [firstpage_image] =>[orig_patent_app_number] => 11364042 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/364042
Expression of heterologous genes according to a targeted expression profile Feb 27, 2006 Abandoned
Array ( [id] => 4866317 [patent_doc_number] => 20080145376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'Vectors And Methods For Genetic Immunization' [patent_app_type] => utility [patent_app_number] => 11/814311 [patent_app_country] => US [patent_app_date] => 2006-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 21494 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0145/20080145376.pdf [firstpage_image] =>[orig_patent_app_number] => 11814311 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/814311
Vectors and methods for genetic immunization Jan 19, 2006 Issued
Array ( [id] => 5733445 [patent_doc_number] => 20060258562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Methods and pharmaceutical compositions for healing wounds' [patent_app_type] => utility [patent_app_number] => 11/332774 [patent_app_country] => US [patent_app_date] => 2006-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 34839 [patent_no_of_claims] => 98 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20060258562.pdf [firstpage_image] =>[orig_patent_app_number] => 11332774 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/332774
Methods and pharmaceutical compositions for healing wounds Jan 16, 2006 Abandoned
Array ( [id] => 5409528 [patent_doc_number] => 20090123426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'Compositions for Bacterial Mediated Gene Silencing and Methods of Using the Same' [patent_app_type] => utility [patent_app_number] => 11/793429 [patent_app_country] => US [patent_app_date] => 2005-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 17635 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20090123426.pdf [firstpage_image] =>[orig_patent_app_number] => 11793429 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/793429
Compositions for Bacterial Mediated Gene Silencing and Methods of Using the Same Dec 15, 2005 Abandoned
Array ( [id] => 5859809 [patent_doc_number] => 20060229268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-12 [patent_title] => 'Small interference RNA (siRNA) molecules for modulating superoxide dismutase (SOD)' [patent_app_type] => utility [patent_app_number] => 11/303452 [patent_app_country] => US [patent_app_date] => 2005-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11784 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20060229268.pdf [firstpage_image] =>[orig_patent_app_number] => 11303452 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/303452
Small interference RNA (siRNA) molecules for modulating superoxide dismutase (SOD) Dec 15, 2005 Abandoned
Array ( [id] => 5306280 [patent_doc_number] => 20090300776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'COMPOSITIONS FOR PREVENTING, REDUCING OR TREATING KERATINOCYTE-MEDIATED INFLAMMATION' [patent_app_type] => utility [patent_app_number] => 11/721763 [patent_app_country] => US [patent_app_date] => 2005-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11735 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20090300776.pdf [firstpage_image] =>[orig_patent_app_number] => 11721763 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/721763
COMPOSITIONS FOR PREVENTING, REDUCING OR TREATING KERATINOCYTE-MEDIATED INFLAMMATION Dec 14, 2005 Abandoned
Array ( [id] => 5304258 [patent_doc_number] => 20090298910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'REGULATION OF EPIGENETIC CONTROL OF GENE EXPRESSION' [patent_app_type] => utility [patent_app_number] => 11/721326 [patent_app_country] => US [patent_app_date] => 2005-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47996 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298910.pdf [firstpage_image] =>[orig_patent_app_number] => 11721326 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/721326
Regulation of epigenetic control of gene expression Dec 11, 2005 Issued
Array ( [id] => 4624323 [patent_doc_number] => 08003619 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-23 [patent_title] => 'Method of stimulating an immune response and inhibiting expression of a gene using an oligonucleotide' [patent_app_type] => utility [patent_app_number] => 11/298850 [patent_app_country] => US [patent_app_date] => 2005-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 6 [patent_no_of_words] => 24514 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/003/08003619.pdf [firstpage_image] =>[orig_patent_app_number] => 11298850 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/298850
Method of stimulating an immune response and inhibiting expression of a gene using an oligonucleotide Dec 8, 2005 Issued
Array ( [id] => 5063039 [patent_doc_number] => 20070224679 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA' [patent_app_type] => utility [patent_app_number] => 11/291390 [patent_app_country] => US [patent_app_date] => 2005-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 17419 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20070224679.pdf [firstpage_image] =>[orig_patent_app_number] => 11291390 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/291390
Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA Nov 30, 2005 Issued
Array ( [id] => 5672975 [patent_doc_number] => 20060178330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Use of antisense oligonucleotides or siRNA to suppress expression of eIF-5A1' [patent_app_type] => utility [patent_app_number] => 11/287460 [patent_app_country] => US [patent_app_date] => 2005-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 101 [patent_figures_cnt] => 101 [patent_no_of_words] => 33736 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20060178330.pdf [firstpage_image] =>[orig_patent_app_number] => 11287460 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/287460
Use of antisense oligonucleotides or siRNA to suppress expression of eIF-5A1 Nov 27, 2005 Issued
Array ( [id] => 5613534 [patent_doc_number] => 20060115462 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => 'Direct DNA delivery to bone cells' [patent_app_type] => utility [patent_app_number] => 11/286719 [patent_app_country] => US [patent_app_date] => 2005-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6381 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20060115462.pdf [firstpage_image] =>[orig_patent_app_number] => 11286719 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/286719
Direct DNA delivery to bone cells Nov 22, 2005 Abandoned
Array ( [id] => 5844366 [patent_doc_number] => 20060122140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'In Vitro and in vivo silencing of human c-myc oncogene expression by poly-DNP-RNA' [patent_app_type] => utility [patent_app_number] => 11/284693 [patent_app_country] => US [patent_app_date] => 2005-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7713 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20060122140.pdf [firstpage_image] =>[orig_patent_app_number] => 11284693 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/284693
In Vitro and in vivo silencing of human c-myc oncogene expression by poly-DNP-RNA Nov 21, 2005 Abandoned
Array ( [id] => 9662311 [patent_doc_number] => 08809287 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-19 [patent_title] => 'Compositions and methods for altering Wnt autocrine signaling' [patent_app_type] => utility [patent_app_number] => 11/719327 [patent_app_country] => US [patent_app_date] => 2005-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 23 [patent_no_of_words] => 17056 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11719327 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/719327
Compositions and methods for altering Wnt autocrine signaling Nov 14, 2005 Issued
Menu